US Spine Surgery Robot Stock Surges Nearly 1 Trillion Won in One Day

Shares of Globus Medical, Inc. (Nasdaq: GMED) jumped 7.15% to close at $80.81 on the New York Stock Exchange on the 17th, lifting the company’s market capitalization to about $9.1 billion (roughly KRW 12.8 trillion)—an increase of approximately $700 million (nearly KRW 1 trillion) in a single day. Trading volume totaled around 1.31 million shares.

In its Q1 2026 earnings released on May 7, Globus Medical posted revenue of $759.85 million and net income of $124.30 million, up 27% and 65% year-over-year, respectively. At the same time, the company issued full-year 2026 guidance of $3.18–3.22 billion in revenue and non-GAAP EPS of $4.70–4.80, signaling confidence in continued growth.

Headquartered in Audubon, Pennsylvania, Globus Medical develops and sells musculoskeletal solutions, including spinal and orthopedic implants and the ExcelsiusGPS robotic system for spine surgery.

In 2023, the company acquired rival NuVasive in a stock-for-stock deal valued at about $3.1 billion (approximately KRW 4.3 trillion). Together with its Nevro acquisition, this move has expanded Globus Medical’s portfolio in the spine and neurostimulation markets, reinforcing its position as a leading musculoskeletal solutions provider.